Home/Filings/4/0000899243-22-035434
4//SEC Filing

Arroyo Santiago 4

Accession 0000899243-22-035434

CIK 0001680581other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 4:15 PM ET

Size

5.6 KB

Accession

0000899243-22-035434

Insider Transaction Report

Form 4
Period: 2022-11-07
Arroyo Santiago
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-11-07+400,000400,000 total
    Exercise: $5.61Exp: 2032-11-06Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]This option was granted on November 7, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of November 7, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.

Issuer

Fulcrum Therapeutics, Inc.

CIK 0001680581

Entity typeother

Related Parties

1
  • filerCIK 0001706857

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:15 PM ET
Size
5.6 KB